NYSE:SENS Senseonics (SENS) Stock Price, News & Analysis → The Overlooked Retirement Asset You Probably Don’t Own (From Crypto 101 Media) (Ad) Free SENS Stock Alerts $0.49 -0.01 (-2.02%) (As of 05/17/2024 ET) Add Compare Share Share Today's Range$0.48▼$0.5050-Day Range$0.40▼$0.6152-Week Range$0.38▼$1.05Volume1.40 million shsAverage Volume2.02 million shsMarket Capitalization$257.53 millionP/E RatioN/ADividend YieldN/APrice Target$1.25 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsSocial Media Get Senseonics alerts: Email Address Senseonics MarketRank™ Stock AnalysisAnalyst RatingHold2.00 Rating ScoreUpside/Downside157.7% Upside$1.25 Price TargetShort InterestN/ADividend StrengthN/ASustainabilityN/ANews Sentiment0.40Based on 12 Articles This WeekInsider TradingN/AProj. Earnings GrowthGrowingFrom ($0.13) to ($0.11) Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.0.90 out of 5 starsMedical Sector810th out of 914 stocksProcess Control Instruments Industry12th out of 12 stocks 3.0 Analyst's Opinion Consensus RatingSenseonics has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on 1 buy rating, no hold ratings, and 1 sell rating.Amount of Analyst CoverageSenseonics has received no research coverage in the past 90 days.Read more about Senseonics' stock forecast and price target. Previous Next N/A Short Interest Short InterestThere is no current short interest data available for SENS. Previous Next 0.0 Dividend Strength Dividend YieldSenseonics does not currently pay a dividend.Dividend GrowthSenseonics does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for SENS. Previous Next 2.4 News and Social Media Coverage News SentimentSenseonics has a news sentiment score of 0.40. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.News Coverage This WeekMarketBeat has tracked 12 news articles for Senseonics this week, compared to 1 article on an average week.Search Interest12 people have searched for SENS on MarketBeat in the last 30 days. This is an increase of 71% compared to the previous 30 days.MarketBeat FollowsOnly 1 people have added Senseonics to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Senseonics insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 3.90% of the stock of Senseonics is held by insiders.Percentage Held by InstitutionsOnly 12.36% of the stock of Senseonics is held by institutions.Read more about Senseonics' insider trading history. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for Senseonics are expected to grow in the coming year, from ($0.13) to ($0.11) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Senseonics is -3.47, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Senseonics is -3.47, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioSenseonics has a P/B Ratio of 12.13. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here Ad True Market Insidersget a piece of the profit from this land This isn’t the prettiest land on earth. But it might be the most valuable. And you don’t have to own, lease, or rent any land.Click here to see my #1 investment for 2024. About Senseonics Stock (NYSE:SENS)Senseonics Holdings, Inc., a medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. The company's products include Eversense, Eversense XL, and Eversense E3 that are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management. It serves healthcare providers and patients through a network of distributors and strategic fulfillment partners. Senseonics Holdings, Inc. was founded in 1996 and is headquartered in Germantown, Maryland.Read More SENS Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart SENS Stock News HeadlinesMay 18 at 2:28 AM | americanbankingnews.comSenseonics (NYSE:SENS) Coverage Initiated at StockNews.comMay 14, 2024 | markets.businessinsider.comStifel Nicolaus Keeps Their Buy Rating on Senseonics Holdings (SENS)May 14, 2024 | msn.comSenseonics Holdings, Inc. (AMEX:SENS) Q1 2024 Earnings Call TranscriptMay 14, 2024 | finance.yahoo.comSenseonics Holdings Inc (SENS) (Q1 2024) Earnings Call Transcript Highlights: Strategic ...May 13, 2024 | msn.comSENS Stock Earnings: Senseonics Holdings Meets EPS, Beats Revenue for Q1 2024May 13, 2024 | sfgate.comSenseonics: Q1 Earnings SnapshotMay 13, 2024 | msn.comMercy to use Senseonics Eversense RPM to monitor diabetic patientsMay 13, 2024 | finance.yahoo.comSenseonics and Mercy Collaborate to Improve Diabetes Population Health ManagementMay 13, 2024 | finance.yahoo.comSenseonics Holdings, Inc. Reports First Quarter 2024 Financial ResultsMay 13, 2024 | businesswire.comSenseonics Holdings, Inc. Reports First Quarter 2024 Financial ResultsMay 13, 2024 | businesswire.comSenseonics and Mercy Collaborate to Improve Diabetes Population Health ManagementMay 10, 2024 | barrons.comSenseonics Holdings Inc.May 9, 2024 | msn.comSenseonics, Rimidi team up on diabetes monitoring solutionMay 9, 2024 | finance.yahoo.comSenseonics Partners with Rimidi to Develop Innovative Diabetes SolutionMay 9, 2024 | businesswire.comSenseonics Partners with Rimidi to Develop Innovative Diabetes SolutionMay 2, 2024 | businesswire.comSenseonics Holdings, Inc. to Participate in Upcoming ConferencesMay 1, 2024 | finance.yahoo.comBird flu testing shows more dairy products are safe, US FDA saysApril 30, 2024 | finance.yahoo.comSenseonics Holdings, Inc. Schedules First Quarter 2024 Earnings Release and Conference Call for May 13, 2024 at 4:30 P.M. Eastern TimeApril 30, 2024 | businesswire.comEversense® CGM System Receives iCGM Designation by the US FDAApril 30, 2024 | businesswire.comEversense® CGM System Receives iCGM Designation by the US FDAApril 29, 2024 | finance.yahoo.comContinuous Glucose Monitoring Market to hit USD 20 Bn by 2032, says Global Market Insights Inc.April 4, 2024 | finance.yahoo.comArtificial Pancreas Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies 2024April 3, 2024 | finance.yahoo.comComprehensive Market Analysis Reveals Significant Insights into the Insulin Pumps and Continuous Glucose Monitors Market Through 2033March 12, 2024 | prnewswire.comSAVINGS OFFER FOR THE EVERSENSE E3 CGM EXTENDED TO COVER UNLIMITED NUMBER OF SYSTEMSMarch 8, 2024 | businesswire.comSenseonics Holdings, Inc. Announces Data From the Eversense® Post Approval Study to Be Presented at the 17th International Conference on Advanced Technologies and Treatments for DiabetesSee More Headlines Receive SENS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Senseonics and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings2/29/2024Today5/19/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry Process control instruments Sub-IndustryN/A Current SymbolNYSE:SENS Previous SymbolNYSE:SENS CUSIPN/A CIK1616543 Webwww.senseonics.com Phone301-515-7260Fax301-515-0988Employees132Year FoundedN/APrice Target and Rating Average Stock Price Target$1.25 High Stock Price Target$2.00 Low Stock Price Target$0.50 Potential Upside/Downside+157.7%Consensus RatingHold Rating Score (0-4)2.00 Research Coverage2 Analysts Profitability EPS (Most Recent Fiscal Year)($0.14) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-60,390,000.00 Net Margins-346.38% Pretax Margin-346.34% Return on Equity-202.32% Return on Assets-56.35% Debt Debt-to-Equity Ratio1.79 Current Ratio3.96 Quick Ratio7.03 Sales & Book Value Annual Sales$22.39 million Price / Sales11.50 Cash FlowN/A Price / Cash FlowN/A Book Value$0.04 per share Price / Book12.13Miscellaneous Outstanding Shares530,890,000Free Float510,181,000Market Cap$257.53 million OptionableN/A Beta0.91 7 Stocks That Could Be Bigger Than Tesla, Nvidia, and GoogleGrowth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.Get This Free Report Key ExecutivesDr. Timothy T. Goodnow Ph.D. (Age 62)President, CEO & Director Comp: $1.34MDr. Mukul Jain (Age 51)Chief Operating Officer Comp: $767.65kMr. Kenneth L. Horton (Age 57)General Counsel & Corporate Development Advisor Comp: $702.33kDr. Francine Ratner Kaufman M.D. (Age 72)Chief Medical Officer & Director Mr. Frederick T. Sullivan (Age 42)CFO, Secretary & Treasurer Key CompetitorsMesa LaboratoriesNASDAQ:MLABuniQureNASDAQ:QURECoherus BioSciencesNASDAQ:CHRSEliem TherapeuticsNASDAQ:ELYMAgenusNASDAQ:AGENView All CompetitorsInsiders & InstitutionsPrice T Rowe Associates Inc. MDBought 51,000 shares on 5/15/2024Ownership: 0.069%Vanguard Group Inc.Bought 155,715 shares on 5/10/2024Ownership: 4.243%State Board of Administration of Florida Retirement SystemBought 170,841 shares on 5/9/2024Ownership: 0.032%Mirae Asset Global Investments Co. Ltd.Bought 211,128 shares on 5/1/2024Ownership: 0.171%Newbridge Financial Services Group Inc.Sold 304,230 shares on 4/24/2024Ownership: 0.026%View All Insider TransactionsView All Institutional Transactions SENS Stock Analysis - Frequently Asked Questions Should I buy or sell Senseonics stock right now? 2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Senseonics in the last twelve months. There are currently 1 sell rating and 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" SENS shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in SENS, but not buy additional shares or sell existing shares. View SENS analyst ratings or view top-rated stocks. What is Senseonics' stock price target for 2024? 2 Wall Street analysts have issued 1 year price targets for Senseonics' stock. Their SENS share price targets range from $0.50 to $2.00. On average, they expect the company's stock price to reach $1.25 in the next year. This suggests a possible upside of 157.7% from the stock's current price. View analysts price targets for SENS or view top-rated stocks among Wall Street analysts. How have SENS shares performed in 2024? Senseonics' stock was trading at $0.5701 at the start of the year. Since then, SENS shares have decreased by 14.9% and is now trading at $0.4851. View the best growth stocks for 2024 here. How were Senseonics' earnings last quarter? Senseonics Holdings, Inc. (NYSE:SENS) announced its quarterly earnings results on Thursday, February, 29th. The company reported ($0.03) EPS for the quarter, beating the consensus estimate of ($0.04) by $0.01. The firm earned $8 million during the quarter, compared to analysts' expectations of $7.62 million. Senseonics had a negative net margin of 346.38% and a negative trailing twelve-month return on equity of 202.32%. What ETF holds Senseonics' stock? Global X Telemedicine & Digital Health ETF holds 504,014 shares of SENS stock, representing 0.53% of its portfolio. When did Senseonics IPO? Senseonics (SENS) raised $45 million in an initial public offering on Friday, March 18th 2016. The company issued 15,800,000 shares at a price of $2.85 per share. Leerink Partners, Canaccord Genuity and Raymond James served as the underwriters for the IPO and BTIG was co-manager. Who are Senseonics' major shareholders? Senseonics' stock is owned by a number of retail and institutional investors. Top institutional shareholders include Vanguard Group Inc. (4.24%), Mirae Asset Global Investments Co. Ltd. (0.17%), Price T Rowe Associates Inc. MD (0.07%), State Board of Administration of Florida Retirement System (0.03%) and Newbridge Financial Services Group Inc. (0.03%). Insiders that own company stock include Anthony R Raab, Douglas A Roeder, Douglas S Prince, Edward Fiorentino, Francine Kaufman, Mirasol Panlilio, Mukul Jain, Nick B Tressler, Sharon Larkin, Stephen P Defalco and Timothy T Goodnow. View institutional ownership trends. How do I buy shares of Senseonics? Shares of SENS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NYSE:SENS) was last updated on 5/19/2024 by MarketBeat.com Staff From Our PartnersBuy this small stock before coming AI Tidal WaveChaikin AnalyticsCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingShocking $16T Elon Musk Crypto LeakCrypto 101 MediaForget Bitcoin: This $8 Stock Is the Next Big ThingBehind the MarketsDems have chosen Biden replacement?Paradigm PressHow Biden has already won 2024Porter & CompanyExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersA letter is coming from the "Bureau of the Fiscal Service".Stansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Senseonics Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.